GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.

China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that targets ...

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Microscopic Polyangiitis (MPA).

The girl, who was admitted to Aster CMI Hospital with alarming breathlessness and significant pallor, was diagnosed with ...

Nasal polyps are fleshy swellings that develop in the lining of the nose and paranasal sinuses, which are the air-filled spaces linked to the nasal cavity. They are noncancerous growths. Polyps ...

Wegener's granulomatosis (newly renamed granulomatosis with polyangiitis [WG/GPA]) is a granulomatous autoimmune inflammatory disorder of unknown etiology that is associated with anti-neutrophil ...